Initially approved in 2012, linaclotide is already indicated for treating chronic idiopathic constipation and IBS-C in adults ...

The FDA expands use of linaclotide to children as young as age 7 years with irritable bowel syndrome with constipation (IBS-C ...

The FDA has updated the label indication for linaclotide capsules for the treatment of irritable bowel syndrome with ...

FDA approves IBS drug for children, Linzess, to treat pediatric IBS-C in patients ages 7 and older with proven safety and efficacy.

The FDA has approved linaclotide (Linzess) capsules for pediatric patients 7 years and older with irritable bowel syndrome with constipation, according to a Nov. 5 news release. Linzess is the first ...

Q3 2025 Earnings Call Transcript November 6, 2025 Novavax, Inc. misses on earnings expectations. Reported EPS is $-1.24654 ...

Two open-label extension studies show that the FcRn blocker nipocalimab has durable efficacy and sustained symptom control ...

A California fruit company has recalled conventional yellow and white peaches sold nationwide at Trader Joe's, Costco, Target ...

A Listeria outbreak has claimed the lives of at least six people and hospitalized dozens more, including two in Louisiana.

The family of two-year-old De'Markus Jeremiah Page has filed a lawsuit against Shands Children's Hospital after his death, ...

To stop the reemergence of measles and other preventable illnesses and avoid unnecessary deaths, Dr. Kube encourages people ...